Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 05
mi
from
Asheville, NC
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 05
mi
from
Asheville, NC
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site
mi
from
Portland, OR
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site
mi
from
Portland, OR
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 13108
mi
from
Pittsburg, PA
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 13108
mi
from
Pittsburg, PA
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 10372
mi
from
Arlington, TX
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 10372
mi
from
Arlington, TX
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site
mi
from
Dallas, TX
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site
mi
from
Houston, TX
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site
mi
from
Houston, TX
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site
mi
from
Houston, TX
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site
mi
from
Houston, TX
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 104
mi
from
Norfolk, VA
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 104
mi
from
Norfolk, VA
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 13504
mi
from
Federal Way, WA
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 13504
mi
from
Federal Way, WA
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 10530
mi
from
Tacoma, WA
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 10530
mi
from
Tacoma, WA
Click here to add this to my saved trials
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated:  3/2/2016
Teva Investigational Site 20029
mi
from
Ciudad de Buenos Aires,
Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
A Phase 3, Multicenter, Randomized, Open-Label, Comparator-Controlled Study to Assess Safety and Tolerability of Weekly TV-1106 Compared to Daily rhGH (dGH) in Adults With Growth Hormone-Deficiency
Status: Enrolling
Updated: 3/2/2016
Teva Investigational Site 20029
mi
from
Ciudad de Buenos Aires,
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Arkansas Children's Hospital
mi
from
Little Rock, AK
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Arkansas Children's Hospital
mi
from
Little Rock, AK
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Arkansas Children's Hospital
mi
from
Little Rock, AR
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Pediatric Endocrinology of San Diego Medical Group Incorporated
mi
from
San Diego, CA
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Pediatric Endocrinology of San Diego Medical Group Incorporated
mi
from
San Diego, CA
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Children's Hospital Colorado
mi
from
Aurora, CO
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Memorial Pediatric Specialty Clinic
mi
from
Colorado Springs, CO
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Memorial Pediatric Specialty Clinic
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Pediatric Endocrine Associates
mi
from
Greenwood Village, CO
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Pediatric Endocrine Associates
mi
from
Greenwood Village, CO
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Pediatric Endocrine Associates at The Longmont Clinic
mi
from
Longmont, CO
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Pediatric Endocrine Associates at The Longmont Clinic
mi
from
Longmont, CO
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Joe DiMaggio Children's Hospital
mi
from
Hollywood, FL
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Joe DiMaggio Children's Hospital
mi
from
Hollywood, FL
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Miller School Of Medicine, University of Miami/Jackson Memorial Medical Center
mi
from
Miami, FL
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Miller School Of Medicine, University of Miami/Jackson Memorial Medical Center
mi
from
Miami, FL
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Pediatric Endocrinology Associates
mi
from
Miami, FL
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Pediatric Endocrinology Associates
mi
from
Miami, FL
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Arnold Palmer Hospital for Children
mi
from
Orlando, FL
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Arnold Palmer Hospital for Children
mi
from
Orlando, FL
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Nemours Children's Clinic
mi
from
Orlando, FL
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Nemours Children's Clinic
mi
from
Orlando, FL
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Nancy Wright, MD
mi
from
Tallahassee, FL
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Nancy Wright, MD
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
University of Iowa Children's Hospital
mi
from
Iowa City, IA
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
University of Iowa Children's Hospital
mi
from
Iowa City, IA
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
University of Maryland, Baltimore
mi
from
Baltimore, MD
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
University of Maryland, Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Johns Hopkins Pediatric Endocrinology
mi
from
Baltimore, MD
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Johns Hopkins Pediatric Endocrinology
mi
from
Baltimore, MD
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Massachusetts General Hospital
mi
from
Boston, MA
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Children's Hospital
mi
from
Boston, MA
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Baystate Medical Center Children's Hospital
mi
from
Springfield, MA
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Baystate Medical Center Children's Hospital
mi
from
Springfield, MA
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Children's Mercy Hospital
mi
from
Kansas City, MO
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Children's Endocrine Care of St. Louis, LLC
mi
from
St. Louis, MO
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Children's Endocrine Care of St. Louis, LLC
mi
from
St. Louis, MO
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Saint Barnabas Ambulatory Care Center
mi
from
Livingston, NJ
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Saint Barnabas Ambulatory Care Center
mi
from
Livingston, NJ
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Morristown Memorial Hospital
mi
from
Morristown, NJ
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Morristown Memorial Hospital
mi
from
Morristown, NJ
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Children's Hospital at Montefiore
mi
from
Bronx, NY
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Children's Hospital at Montefiore
mi
from
Bronx, NY
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Maimonides Medical Center
mi
from
Brooklyn, NY
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Maimonides Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Women and Children's Hospital of Buffalo
mi
from
Buffalo, NY
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Women and Children's Hospital of Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
The Steven and Alexandra Cohen Children's Medical Center of New York (CCMC)
mi
from
Lake Success, NY
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
The Steven and Alexandra Cohen Children's Medical Center of New York (CCMC)
mi
from
Lake Success, NY
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Winthrop University Hospital
mi
from
Mineola, NY
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Mount Sinai School of Medicine
mi
from
New York, NY
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Diabetes & Endocrine Center for Children & Young Adults at Phelps Memorial Hospital
mi
from
Sleepy Hollow, NY
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Diabetes & Endocrine Center for Children & Young Adults at Phelps Memorial Hospital
mi
from
Sleepy Hollow, NY
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
The Research Institute at Nationwide Children's Hospital
mi
from
Columbus, OH
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
The Research Institute at Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Central Ohio Pediatric Endocrinology/Diabetes Services (COPEDS)
mi
from
Columbus, OH
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Central Ohio Pediatric Endocrinology/Diabetes Services (COPEDS)
mi
from
Columbus, OH
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Thomas Jefferson University
mi
from
Philadelphia, PA
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated:  3/9/2016
Pediatric Alliance, PC
mi
from
Pittsburgh, PA
Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature
A Four Year Open Label Multi Center Randomized Two Arm Study Of Genotropin In Idiopathic Short Stature Patients: Comparing An Individualized, Target Driven Treatment Regimen To Standard Dosing Of Genotropin
Status: Enrolling
Updated: 3/9/2016
Pediatric Alliance, PC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials